REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Yarinvest Medical OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Yarinvest Medical OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Yarinvest Medical OOO is based in Russia. The head office is in Yaroslavl. The company operates in the Pharmacies and Drug Stores industry. It was first established on December 04, 2002. The total number of employees is currently 67 (2023). The latest financial highlights indicate a net sales revenue drop of 12.85% in 2023. Its’ total assets recorded a negative growth of 13.97%. The enterprise’s net profit margin decreased by 1.01% in 2023.

Headquarters
Svobody, 8/38
Yaroslavl; Yaroslavl Oblast; Postal Code: 150000

Contact Details: Purchase the Yarinvest Medical OOO report to view the information.

Website: http://www.rinolife.ru

Basic Information
Total Employees:
Purchase the Yarinvest Medical OOO report to view the information.
Outstanding Shares:
Purchase the Yarinvest Medical OOO report to view the information.
Registered Capital:
Purchase the Yarinvest Medical OOO report to view the information.
Incorporation Date:
December 04, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
49%
Purchase this report to view the information.
1%
Subsidiaries
Bell OOO
100%
Rinolaif OOO
22%
Company Performance
Financial values in the chart are available after Yarinvest Medical OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-12.85%▼
Total operating revenue
-12.85%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-73.33%▼
Total assets
-13.97%▼
Total equity
-17.26%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-1.01%▼
Return on Equity (ROE)
-9.67%▼
Quick Ratio
-0.02%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo